Commonwealth Bank of Australia’s United Therapeutics UTHR Stock Holding History

Commonwealth Bank of Australia’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$15K	–	909
2019 Q2	$15K	Hold	200	–	–	﹤0.01%	1063
2019 Q1	$23K	Buy	200 +100	+100%	+$11.7K	﹤0.01%	1016
2018 Q4	$10K	Hold	100	–	–	﹤0.01%	1086
2018 Q3	$12K	Hold	100	–	–	﹤0.01%	1105
2018 Q2	$11K	Hold	100	–	–	﹤0.01%	785
2018 Q1	$11K	Hold	100	–	–	﹤0.01%	763
2017 Q4	$14K	Hold	100	–	–	﹤0.01%	742
2017 Q3	$11K	Sell	100 -800	-89%	-$102K	﹤0.01%	759
2017 Q2	$116K	Hold	900	–	–	﹤0.01%	681
2017 Q1	$122K	Hold	900	–	–	﹤0.01%	654
2016 Q4	$129K	Buy	900 +100	+13%	+$12.8K	﹤0.01%	608
2016 Q3	$94K	Buy	800 +100	+14%	+$12K	﹤0.01%	649
2016 Q2	$74K	Buy	700 +300	+75%	+$33.5K	﹤0.01%	666
2016 Q1	$45K	Buy	400 +100	+33%	+$12.7K	﹤0.01%	767
2015 Q4	$47K	Buy	300 +200	+200%	+$29.1K	﹤0.01%	772
2015 Q3	$13K	Buy	+100	New	+$16K	﹤0.01%	832
2014 Q2	–	Sell	-141,495	Closed	-$13.3M	–	1022
2014 Q1	$13.3M	Sell	141,495 -29,527	-17%	-$3.02M	0.09%	230
2013 Q4	$19.3M	Sell	171,022 -22,122	-11%	-$1.99M	0.13%	159
2013 Q3	$15.2M	Hold	193,144	–	–	0.11%	185
2013 Q2	$12.7M	Buy	+193,144	New	+$12.4M	0.1%	204

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Commonwealth Bank of Australia's UTHR Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of United Therapeutics (UTHR) in Q3 2019, closing a stake of 200 shares — an estimated $15K sold.

Commonwealth Bank of Australia first reported a position in UTHR in Q2 2013 and held it in 20 quarters. The position peaked at $19.3M in Q4 2013. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

Commonwealth Bank of Australia reported no remaining United Therapeutics position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 200 United Therapeutics shares in Q3 2019, an estimated $15K.
Commonwealth Bank of Australia first reported a position in United Therapeutics in Q2 2013 and held it in 20 quarters.
Commonwealth Bank of Australia's United Therapeutics position peaked at $19.3M in Q4 2013.
302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.